GO:0043015 gamma-tubulin binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0043015 gamma-tubulin binding is a molecular function defined as binding to the microtubule constituent protein gamma-tubulin.
• Gamma-tubulin binding underlies the assembly and regulation of gamma-tubulin complexes, which nucleate and cap microtubules.
• Key proteins that bind gamma-tubulin include gamma-tubulin complex proteins (TUBGCPs), Mozart1, centrosomin motif 1-containing proteins, and alpha-fodrin.
• Gamma-tubulin binding is regulated by nucleotide state, autoinhibitory mechanisms, and subcellular targeting.
• Dysregulation of gamma-tubulin binding is linked to cell division defects and cancer-relevant microtubule dynamics.
• CRISPR knockout, point mutation, knock-in, and overexpression models enable causal dissection of gamma-tubulin binding in cells.
Description
Gamma-tubulin binding (GO:0043015) is a molecular function that describes the physical interaction with gamma-tubulin, a conserved tubulin family member that serves as the core of microtubule nucleation sites. Unlike alpha- and beta-tubulin, gamma-tubulin does not form the main microtubule lattice but instead seeds and caps microtubules, making its binding partners central to cytoskeletal organization. Researchers study this term because gamma-tubulin binding proteins control spindle assembly, microtubule array formation, and cell division, processes that are frequently altered in disease. The interaction is not a single static event: it involves nucleotide-dependent conformational changes, autoinhibitory regulation, and competition among diverse binding partners. Understanding GO:0043015 therefore requires integrating structural, biochemical, and cell biological evidence from studies of gamma-tubulin complexes and their regulators.
gamma-tubulin binding At A Glance
| GO ID | GO:0043015 |
|---|---|
| GO term | gamma-tubulin binding |
| Ontology | molecular_function |
| Synonym | gamma tubulin binding |
| Major function | Binding to gamma-tubulin, enabling microtubule nucleation, capping, and complex assembly |
| Related complexes | Gamma-tubulin small complex (gamma-TuSC) and gamma-tubulin ring complex (gamma-TuRC) |
| Key regulators | Nucleotide state, autoinhibitory domains, and subcellular targeting factors |
| Disease relevance | Cell division defects and cancer-associated microtubule dysregulation |
What Is GO:0043015?
In the Gene Ontology, GO:0043015 gamma-tubulin binding is defined as binding to the microtubule constituent protein gamma-tubulin. It is a molecular_function term, meaning it describes a molecular-level activity rather than a biological process or cellular component. The synonym gamma tubulin binding is used interchangeably. This function is typically measured by co-immunoprecipitation, pull-down assays, FRET, or structural methods that detect direct interaction with gamma-tubulin.
Why Is gamma-tubulin binding Important in Cell Biology?
Gamma-tubulin binding is important because gamma-tubulin is the seed for microtubule nucleation, and proteins that bind it determine where and when microtubules form. This function is essential for mitotic spindle assembly, centrosome function, and non-centrosomal microtubule arrays. Because microtubule organization is a hallmark of cell division and is targeted by anticancer drugs, understanding gamma-tubulin binding provides mechanistic insight into proliferation control and potential therapeutic vulnerabilities.
• Controls microtubule nucleation and capping, which are required for mitotic spindle formation.
• Regulates assembly and activity of gamma-tubulin small and ring complexes.
• Determines subcellular targeting of gamma-tubulin complexes to centrosomes and other sites.
• Is modulated by nucleotide binding and autoinhibitory mechanisms.
• Influences cell division fidelity and genome stability.
• Provides a molecular explanation for how alpha-fodrin inhibits microtubule nucleation.
• Links cytoskeletal regulation to cancer cell proliferation.
• Offers targets for experimental perturbation using CRISPR-based models.
• Supports research on non-centrosomal microtubule arrays in differentiated cells.
• Helps interpret mutations in gamma-tubulin complex genes in disease contexts.
Molecular Mechanism of gamma-tubulin binding
Nucleotide-dependent interaction with gamma-tubulin
In simple terms: Gamma-tubulin can bind guanine nucleotides, and this binding changes how it interacts with partner proteins.
FRET-based analysis has shown that guanine nucleotide binding to gamma-tubulin can be measured directly and that the nucleotide state influences conformational behavior. A nucleotide binding-independent role for gamma-tubulin in microtubule capping and cell division has also been demonstrated, indicating that some binding events do not strictly require nucleotide hydrolysis. Together, these findings suggest that gamma-tubulin binding partners must be evaluated in the context of gamma-tubulin's nucleotide state.
Assembly and regulation of gamma-tubulin complexes
In simple terms: Gamma-tubulin works in large complexes, and binding to these complexes is tightly regulated.
Gamma-tubulin complexes bind to the centrosome and are regulated during the cell cycle to nucleate microtubules. Assembly and regulation of gamma-tubulin complexes involve multiple gamma-tubulin complex proteins and accessory factors. These complexes form the gamma-tubulin small complex and the larger gamma-tubulin ring complex, which serve as templates for microtubule nucleation.
Autoinhibitory control of gamma-tubulin ring complex binding
In simple terms: Some proteins are kept inactive until a conformational change allows them to bind the gamma-tubulin ring complex.
An autoinhibitory mechanism controls binding of centrosomin motif 1 to the gamma-tubulin ring complex. This means that the binding interface is masked until relief of autoinhibition, providing a switch for activating microtubule nucleation. Such regulation ensures that gamma-tubulin binding is spatially and temporally restricted.
Promiscuous and competitive binding by microproteins
In simple terms: Small proteins can bind gamma-tubulin complexes in multiple ways, which helps target them to specific cellular locations.
The microprotein Mozart1 binds gamma-tubulin complex components promiscuously, and this binding mediates specific subcellular targeting to control microtubule array formation. This illustrates that gamma-tubulin binding is not limited to canonical gamma-tubulin complex proteins and can involve small regulatory polypeptides.
Inhibition of microtubule nucleation by alpha-fodrin
In simple terms: Alpha-fodrin binds gamma-tubulin and blocks microtubule nucleation.
Binding of alpha-fodrin to gamma-tubulin accounts for its role in the inhibition of microtubule nucleation. This provides an example of a non-canonical gamma-tubulin binding partner that negatively regulates nucleation. It also shows that GO:0043015 includes inhibitory interactions, not only activating ones.
Key Genes Involved in GO:0043015 gamma-tubulin binding
The following genes and proteins are experimentally implicated in gamma-tubulin binding or in the regulation of gamma-tubulin complexes.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TUBG1 | Gamma-tubulin, the core binding target | Central to microtubule nucleation and capping |
| TUBG2 | Gamma-tubulin family member | Studied in gamma-tubulin complex assembly |
| TUBGCP2 | Gamma-tubulin complex protein | Component of gamma-tubulin small and ring complexes |
| TUBGCP3 | Gamma-tubulin complex protein | Required for gamma-tubulin ring complex assembly |
| TUBGCP4 | Gamma-tubulin complex protein | Contributes to complex regulation |
| TUBGCP5 | Gamma-tubulin complex protein | Part of gamma-tubulin ring complex |
| TUBGCP6 | Gamma-tubulin complex protein | Part of gamma-tubulin ring complex |
| MOZART1 | Microprotein binding gamma-tubulin complex | Mediates subcellular targeting and microtubule array formation |
| CNTROB | Centrosomin motif 1-containing protein | Autoinhibitory binding to gamma-tubulin ring complex |
| SPTAN1 | Alpha-fodrin, gamma-tubulin binding protein | Inhibits microtubule nucleation |
| NEDD1 | Gamma-tubulin ring complex targeting factor | Regulates complex localization |
| CDK5RAP2 | Centrosomin motif 1 protein | Activates gamma-tubulin ring complex |
| AKAP9 | Centrosomal scaffold | Associated with gamma-tubulin complex regulation |
| PLK1 | Mitotic kinase | Regulates centrosome and gamma-tubulin function |
| AURKA | Mitotic kinase | Regulates centrosome maturation and gamma-tubulin recruitment |
| TP53 | Tumor suppressor | Context for cell division defects linked to gamma-tubulin dysfunction |
| MZT1 | Microprotein partner of gamma-tubulin complex | Controls complex assembly and targeting |
How Is gamma-tubulin binding Regulated?
Gamma-tubulin binding is regulated at multiple levels. Nucleotide binding to gamma-tubulin influences its conformational state and interaction with partners. Autoinhibitory domains in proteins such as centrosomin motif 1-containing factors prevent premature binding to the gamma-tubulin ring complex until activation signals relieve inhibition. Subcellular targeting factors, including microproteins like Mozart1, direct gamma-tubulin complexes to specific sites and thereby control where microtubule arrays form. Cell cycle kinases such as PLK1 and AURKA regulate centrosome maturation and gamma-tubulin recruitment, indirectly controlling gamma-tubulin binding events. Finally, the assembly state of gamma-tubulin small and ring complexes determines which binding interfaces are available.
gamma-tubulin binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TUBG1 | Cell division defects and cancer-relevant microtubule dysfunction | Knockout and point-mutation cell lines |
| TUBGCP2 | Gamma-tubulin complex assembly defects | Knock-in of patient variants |
| TUBGCP3 | Microtubule nucleation disorders | Knockout with rescue |
| MOZART1 | Non-centrosomal microtubule array dysfunction | Overexpression and tagged knock-in |
| SPTAN1 | Microtubule nucleation inhibition | Knockout and binding-domain mutation |
Cancer and cell division defects
Gamma-tubulin binding is essential for mitotic spindle assembly, and its perturbation can lead to cell division errors. Because microtubule organization is a target of anticancer therapies, proteins that bind gamma-tubulin are of interest in cancer research. Dysregulated centrosome function and gamma-tubulin complex activity have been associated with chromosomal instability in tumor cells.
Microtubule nucleation disorders
Alpha-fodrin binding to gamma-tubulin inhibits microtubule nucleation, linking gamma-tubulin binding to regulation of microtubule density. Defects in gamma-tubulin complex assembly can impair microtubule nucleation and are relevant to developmental and degenerative conditions. Understanding these interactions may clarify how cells maintain cytoskeletal homeostasis.
Non-centrosomal microtubule array dysfunction
Mozart1 binding to gamma-tubulin complexes controls subcellular targeting and microtubule array formation. Disruption of such targeting could affect differentiated cells that rely on non-centrosomal microtubule arrays. This area remains an active research frontier for linking gamma-tubulin binding to tissue-specific functions.
From gamma-tubulin binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is TUBG1 required for mitotic spindle assembly? | CRISPR knockout cell line |
| Does a specific gamma-tubulin residue control nucleotide-dependent binding? | Point-mutation knock-in |
| How does Mozart1 targeting affect microtubule arrays? | Tagged knock-in and overexpression |
| Does alpha-fodrin binding inhibit nucleation in vivo? | Knockout of binding domain |
| Which gamma-tubulin complex proteins are essential? | Multiplex knockout |
| Can autoinhibition of centrosomin motif 1 be relieved by mutation? | Point-mutation knock-in |
How to Study the gamma-tubulin binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Co-immunoprecipitation | Physical interaction with gamma-tubulin | Assigning GO:0043015 to a protein |
| FRET | Nucleotide-dependent conformational changes | Measuring guanine nucleotide binding to gamma-tubulin |
| GST pull-down | Direct binding in vitro | Mapping binding domains |
| Fluorescence microscopy | Subcellular localization and microtubule arrays | Assessing targeting and array formation |
| Live-cell imaging | Mitotic spindle dynamics | Evaluating cell division defects |
| Biochemical fractionation | Complex assembly state | Studying gamma-tubulin small and ring complexes |
| CRISPR knockout | Loss-of-function phenotype | Testing requirement for gamma-tubulin binding |
| Point-mutation knock-in | Specific residue function | Dissecting autoinhibitory interfaces |
Binding assays for gamma-tubulin interaction
Co-immunoprecipitation, GST pull-down, and FRET-based assays are used to detect and quantify gamma-tubulin binding. FRET-based analysis specifically enables measurement of guanine nucleotide binding to gamma-tubulin and its impact on partner interactions. These methods are foundational for assigning GO:0043015 to a protein.
Structural and complex assembly analysis
Biochemical fractionation and structural approaches reveal how gamma-tubulin small and ring complexes assemble and which interfaces mediate binding. Autoinhibitory mechanisms can be mapped by comparing wild-type and mutant proteins. Such studies clarify the molecular determinants of gamma-tubulin binding.
Live-cell imaging of microtubule arrays
Fluorescence microscopy of tagged gamma-tubulin and its binding partners allows visualization of subcellular targeting and microtubule array formation. Time-lapse imaging can assess mitotic spindle defects after perturbation. These approaches connect molecular binding to cellular phenotypes.
Genetic perturbation and phenotyping
CRISPR knockout, point mutation, and overexpression models are used to test causality of gamma-tubulin binding in cell division and microtubule organization. Phenotypic readouts include spindle morphology, microtubule nucleation rates, and cell cycle progression. Combining genetics with biochemistry provides robust evidence for function.
How CRISPR Can Be Used to Study GO:0043015 gamma-tubulin binding
Knockout
CRISPR knockout of gamma-tubulin or its binding partners can reveal whether the interaction is required for microtubule nucleation and cell division. Knockout cell lines are useful for rescue experiments with wild-type or mutant constructs. This approach helps establish causality for GO:0043015-associated phenotypes.
Point Mutation
Point mutations in gamma-tubulin or partner proteins can test the role of specific residues in binding and nucleotide-dependent regulation. For example, mutations that relieve autoinhibition of centrosomin motif 1 can be introduced to study gamma-tubulin ring complex activation. Such models provide fine-grained mechanistic insight.
Knock-in
Knock-in of tagged or disease-associated variants allows tracking of gamma-tubulin binding proteins in their endogenous context. Tagged knock-in of Mozart1 or gamma-tubulin complex components enables localization studies. This strategy preserves physiological expression levels while enabling detection.
Overexpression
Overexpression of gamma-tubulin binding proteins such as alpha-fodrin or Mozart1 can test dominant effects on microtubule nucleation and array formation. Overexpression models are particularly useful when loss-of-function is lethal or masked by redundancy. They complement knockout and knock-in approaches.
How EDITGENE Supports gamma-tubulin binding Research
Researchers studying gamma-tubulin binding-related genes often need to determine whether a candidate gene is causally involved in microtubule nucleation, cell division, or disease-associated phenotypes. EDITGENE provides CRISPR-based cell model services that enable precise perturbation of gamma-tubulin binding genes, from complete knockout to subtle point mutations, knock-ins, and overexpression, supported by library screening and bioinformatics.
Contact EDITGENE today to design your custom CRISPR model for gamma-tubulin binding research.
Frequently Asked Questions About gamma-tubulin binding
What is gamma-tubulin binding?
Gamma-tubulin binding (GO:0043015) is a molecular function defined as binding to the microtubule constituent protein gamma-tubulin.
What genes are involved in gamma-tubulin binding?
Genes include TUBG1, TUBG2, TUBGCP2-6, MOZART1, CNTROB, SPTAN1, and NEDD1, among others.
What is the GO ID for gamma-tubulin binding?
The GO ID is GO:0043015, a molecular_function term.
How is gamma-tubulin binding measured?
It is measured by co-immunoprecipitation, pull-down assays, FRET, and structural methods.
Why is gamma-tubulin binding important for cell division?
It controls microtubule nucleation and capping, which are required for mitotic spindle assembly.
What is the role of Mozart1 in gamma-tubulin binding?
Mozart1 binds gamma-tubulin complexes promiscuously to mediate subcellular targeting and microtubule array formation.
Does alpha-fodrin bind gamma-tubulin?
Yes, alpha-fodrin binds gamma-tubulin and inhibits microtubule nucleation.
How is gamma-tubulin binding regulated?
It is regulated by nucleotide state, autoinhibitory mechanisms, and subcellular targeting factors.
What diseases are linked to gamma-tubulin binding?
Dysregulation is linked to cell division defects and cancer-relevant microtubule dynamics.
Can CRISPR be used to study gamma-tubulin binding?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable causal studies of gamma-tubulin binding.
Conclusion
GO:0043015 gamma-tubulin binding is a central molecular function for microtubule nucleation, capping, and cell division. Its mechanisms involve nucleotide-dependent interactions, autoinhibitory regulation, and diverse binding partners such as gamma-tubulin complex proteins, Mozart1, centrosomin motif 1 proteins, and alpha-fodrin. Studying this function with CRISPR-based models and biochemical assays provides mechanistic insight into cytoskeletal regulation and disease-relevant cell division defects.
References
- 1. Berman AY et al.. 2023. A nucleotide binding-independent role for γ-tubulin in microtubule capping and cell division.. J Cell Biol 222(3) PMID: 36695784
- 2. Schiebel E. 2000. gamma-tubulin complexes: binding to the centrosome, regulation and microtubule nucleation.. Curr Opin Cell Biol 12(1):113-8 PMID: 10679351
- 3. Sreeja JS et al.. 2019. Binding of alpha-fodrin to gamma-tubulin accounts for its role in the inhibition of microtubule nucleation.. FEBS Lett 593(11):1154-1165 PMID: 31062342
- 4. Huang TL et al.. 2020. Promiscuous Binding of Microprotein Mozart1 to γ-Tubulin Complex Mediates Specific Subcellular Targeting to Control Microtubule Array Formation.. Cell Rep 31(13):107836 PMID: 32610137
- 5. Yin C et al.. 2026. FRET-based analysis of guanine nucleotide binding to γ-tubulin.. Mol Biol Cell 37(5):ar46 PMID: 41926338
- 6. Yang S et al.. 2023. Autoinhibitory mechanism controls binding of centrosomin motif 1 to γ-tubulin ring complex.. J Cell Biol 222(7) PMID: 37213089
- 7. Kristensson MA. 2021. The Game of Tubulins.. Cells 10(4) PMID: 33800665
- 8. Farache D et al.. 2018. Assembly and regulation of γ-tubulin complexes.. Open Biol 8(3) PMID: 29514869
